Literature DB >> 19556767

Current status of central concentrate delivery system for hemodialysis in Korea.

Sang-Woong Han1, Joo-Hark Yi, Ho-Jung Kim.   

Abstract

So far, less than 10% of hemodialysis (HD) facilities in Korea have adopted a kind of central delivery system (CDS) for dialysates, the so-called Korean central concentrate delivery system (CCDS). In our CCDS, all concentrate solutions of the acid and bicarbonate dry powder mixed with the treated reverse osmosis (RO) water in the mixing tank and stored in the holding tank are centrally delivered to individual HD machines via two streams along with a one further stream for dilution RO water. This mode of Korean CCDS is different from the central dialysate delivery system (CDDS), which uses already fully proportioned acid and bicarbonate concentrates with dilution RO water delivering it via a single stream. At present, the most popular CCDS in Korea is NephroMix Premium, which is an all-in-one system that combines the mixing tank, the holding tank, and the control functions into one unified case. Moreover, all CCDS data can be monitored in real-time through a user-friendly touch-screen panel, and stored on a desktop PC linked to the manufacturer's main office. For the disinfection and sterility of NephroMix Premium, ozone is used besides a three-step filtering system for removing endotoxin and microbials. Compared to the conventional system in Korea with individual concentrate delivery to single-patient dialysis machines, the Korean-style CCDS seems to be superb in the way of convenience, environmental friendliness, and economy, and also needs less space in the dialysis unit. However, full proof of its safety and effectiveness is required for further verification in the future. (c) 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 19556767     DOI: 10.1159/000213501

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  1 in total

1.  A randomized cross-over study comparing the performance of HD integra™ central concentrate system versus pre-produced concentrate in hemodialysis.

Authors:  K Fauziah; K W Go; A Ghazali; M Zaki; T O Lim
Journal:  BMC Nephrol       Date:  2017-04-03       Impact factor: 2.388

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.